Peeter Padrik, MD, PhD

Medical Oncologist, Tartu University Hospital, Estonia Founder and CEO of Antegenes, A Precision Medicine Company, Estonia

Dr. Peeter Padrik is a medical oncologist, scientist, and healthcare entrepreneur with more than 30 years of experience in clinical, research, leadership, and healthcare management roles. He has served as the Head of the Haematology & Oncology Clinic, Director of the Cancer Centre at Tartu University Hospital, and Associate Professor of Oncology at the University of Tartu. Dr. Padrik is a medical oncologist with breast cancer patients at Tartu University Hospital, Tartu, Estonia. Dr. Padrik is also a pioneer in incorporating innovative genetic information into healthcare, initially through research projects and academic clinical practice, and is currently the Founder and CEO of Antegenes. Antegenes is a health-tech company, clinic, and lab that develops and implements personalized cancer prevention strategies using innovative clinical genetic tests based on polygenic risk score (PRS) technology. Antegenes has developed into clinical use innovative PRS test for breast cancer and a model for genetics-based personalized breast cancer prevention. Dr. Padrik’s vision and goal are to extend the life expectancy of individuals by integrating genetics-based personalized prevention strategies against common cancers.